Business MindMed Announces C$19.5 Million Bought Deal Private Placement Offering Louise Sommerfeld Mar 8, 2021 0
Mydecine Innovations’ Josh Bartch: The Last 12 Months Have Been Monumental For The Industry Mar 4, 2021
PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract… Mar 2, 2021
PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou… Mar 2, 2021
Mydecine Innovations: Unlocking Fungi’s Pharmacological and Nutraceutical Healing Properties Mar 1, 2021
Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and… Mar 1, 2021
Accessible Neuroimaging Could Change Future of Psychedelic Therapy; Cybin’s Newest Collaboration Feb 28, 2021
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion… Feb 26, 2021
PsyBio Therapeutics Comes To Market With Compelling Psychedelic Compound Synthesis Technology Feb 25, 2021
PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics… Feb 25, 2021
Insufficient Qualified Healthcare Professionals Prompts Demand for Psychedelic Training Programs Feb 24, 2021
Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) Feb 24, 2021
PharmaTher Announces Research Collaboration with Terasaki Institute for Novel Microneedle Delivery of Psychedelic… Feb 23, 2021
Mindset Pharma Agrees to Manufacture Large Quantity of Pharmaceutical Grade Psilocybin Using Patent-Pending Synthesis… Feb 22, 2021
Mountain Valley MD To Include Testing Of South African Mutation In Upcoming COVID-19 BSL-4 Clearance Work Feb 22, 2021
Numinus’ Dr Evan Wood: There is Nothing Like Psychedelics to Treat Mental Health Challenges Feb 22, 2021
Microdosing DMT for Stroke: Algernon Pharmaceuticals Launches New Clinical Research Program Feb 12, 2021
MYND Life Sciences Signs Collaborative Research Agreement with UBC to Study Major Depression Feb 6, 2021
MINDCURE Helping Canadians Pursue “Mental Wealth” with Psychedelic Supplements and Digital Therapeutics Feb 5, 2021
